use of changeri ghrita and bala tail in the management of rectal prolapse
Not Applicable
- Conditions
- Health Condition 1: 8- Other Procedures
- Registration Number
- CTRI/2021/03/032180
- Lead Sponsor
- dr kirti saini
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.children of either gender,1.5-5 year of age diagnosed to have rectal prolapse.
2.frequent diarrohea and constipation.
3.recurrent prolapse
4.chronic straining
Exclusion Criteria
Children having complete prolapse.
ï?· Children above 5 year age.
1. Children with severe systemic illness.
2.Previous history of surgery on pelvic floor, Neurological diseases like neural
3.tube defects and congenital megacolon, rectal polyps were the exclusion
criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the research drug is expected to be beneficial for improving symptoms of rectal prolapse like pravahna, vibhanda,atisara, bleeding per anus, pain in abdomen & other symptoms to manage the disease at medicinal level,for improving qualuity of life& prevent from detrimentals of the surgery.Timepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method the trial drug strengthen the musculature of anal region, nourishes the body and releives the vataj symptoms like pain, dryness,constipation,etc.Timepoint: 4 weeks